Introduction {#s0005}
============

Seventeen years ago, while updating the fourth edition of the French standard textbook *Dermatologie et Infections Sexuellement Transmissibles,* I had some difficulties classifying a few entities, such as *eruptive pseudoangiomatosis, Gianotti-Crosti syndrome, pityriasis rosea, acute perifluxural exanthema of childhood,* and the *papular-purpuric gloves and socks syndrome.*

Although these eruptions are thought of as being of viral origin, they have been reported to be triggered by many different viruses and not a single virus, and sometimes even by other agents, such as drugs. The papular-purpuric gloves and socks syndrome, for example, was initially described in patients with parvovirus B19 infection, but a similar clinical appearance was then reported with many other viruses: Epstein-Barr virus, cytomegalovirus, hepatitis B, measles, varicella, human herpes virus 6, human immunodeficiency virus, and others. When organizing knowledge in a textbook, or when teaching students, it would thus have been wrong to classify the papular-purpuric gloves and socks syndrome as a manifestation of parvovirus B19. To address this nosologic vacuum, the term "paraviral eruptions" was coined, introduced in the textbook and shared with the medical community.[@bb0005] ^,^ [@bb0010]

While carefully examining those entities, it became clear that they had many similarities and that they substantially differed from classic viral exanthems. A classic viral exanthem is usually short-lived, lasting only a few days, typically associated with one virus or family of viruses; microscopic evaluation of the eruption shows a cytopathogenic viral effect, demonstrating a direct interaction between the virus and the skin.

Paraviral eruptions on the contrary have the following characteristics. They are highly recognizable by an experienced physician; the physician will name them and will not refer to the causal agent ("this is a Gianotti-Crosti syndrome"). They are thus defined by morphology and not etiology. Many different viruses can trigger the same type of eruption. They usually persist for a few weeks. On microscopic examination, there is no cytopathogenic viral effect.

One basic difference between a classic viral eruption and a paraviral eruption is that the skin lesions result from a direct interaction between the virus and the skin in the former, and they are a consequence of an immune reaction triggered by the virus in the latter.

Since the concept was created, it has gained wide acceptance in the French nosography. [Table 1](#t0005){ref-type="table"} summarizes the entities that are included in the current edition (sixth edition) of our textbook.[@bb0010] Of note, many dermatologic entities that are already otherwise classified in nosography, such as vasculitides, urticaria, and erythema nodosum, can also be considered in some instances as paraviral eruptions.Table 1Paraviral eruptions[@bb0010]Table 1Clinical syndromeMain associated virusOther virusesNosology*Otherwise undefined nosology*Papular acrodermatitis (Gianotti-Crosti syndrome)Hepatitis BMultipleParaviral eruptionPapular-purpuric gloves and socks syndromeParvovirus B19MultipleParaviral eruptionPityriasis roseaHHV7HHV6Paraviral eruptionAcute periflexural exanthema of childhoodUnknownParvovirus B19, HHV7Paraviral eruptionEruptive pseudoangiomatosisUnknownParvovirus B19, enterovirus, EBVParaviral eruption  *Defined nosology*Erythema multiformeHerpes simplexNot establishedBullous disorderErythema nodosumNoneMultipleSeptal panniculitisSweet syndromeNoneMultipleNeutrophilic dermatosisAcute exanthematic generalized pustulosisEnterovirusParvovirus B19Neutrophilic dermatosisUrticariaNoneMultipleUrticariaLichen striatus/blaschkitisUnknownNot establishedBlaschkolinear dermatosisVasculitisHepatitisMultipleVasculitisPityriasis lichenoidesUnknownMultipleVasculitis (lymphocytic)Drug reaction with eosinophilia and systemic clinical manifestationsHHV6EBV, CMVDrug reaction[^1]

Skin findings in patients with COVID-19 {#s0015}
=======================================

It is too early to provide an exhaustive classification of all the skin findings observed in patients with COVID-19. Never before in medicine and in our modern societies has a single topic, namely, COVID-19, been so present in the media, the politics, the minds, and the medical journals worldwide. This monothematic rush leads to considerable irrational behavior and precipitation. Even the most prestigious medical journals, such as *The New England Journal of Medicine* or *The Lancet,* rushed to publish contributions on COVID-19, only to retract the contributions shortly after their publication.[@bb0015] ^,^ [@bb0020] Unfortunately, the mere publication has immediately led to discontinuation of major clinical trials.

I shall only focus on two skin findings that are related to COVID-19 and have a relative high degree of reliability. They have occurred in many patients during the pandemic, and they have been reported by different and independent investigators. For all of the numerous other reported skin findings, only time will let us know if they occurred by simple coincidence, or if they were causally related to COVID-19.

A classic viral eruption has been reported in patients with COVID-19.[@bb0025] ^,^ [@bb0030] It is a localized or widespread nonpruritic or mildly pruritic vesicular eruption, involving mainly the trunk. Mucosal involvement has so far not been reported, though mucosal involvement can occur during COVID-19.[@bb0035] Papules and pustules are often also present, and in some patients the eruption is monomorphic and reminiscent of Grover disease ([Figure 1](#f0005){ref-type="fig"} ). A few patients were biopsied, and histopathologic evaluation revealed cytopathogenic changes typical of a viral eruption, with reticular degeneration of the epidermis, dyskeratotic, sometimes multinucleate keratinocytes, and foci of acantholysis.[@bb0025] ^,^ [@bb0030] ^,^ [@bb0040] This eruption usually started a few days after the first signs of COVID-19, lasted about a week, and resolved without sequelae. In many patients, SARS-CoV-2 could be demonstrated by nasopharyngeal swabs. The severity of COVID-19 was variable. Ten of 24 (42%) Spanish patients with such an eruption developed pneumonia,[@bb0030] whereas 3 of 22 Italian patients died.[@bb0025] Fig. 1Monomorphic papulovesicular and excoriated mildly pruritic eruption in a 54-year-old man with positive severe acute respiratory syndrome coronavirus 2 nasopharyngeal swab. The eruption appeared 6 days after fever, chills, and myalgia, and the patient also developed dysgeusia.Fig. 1

For the second eruption, an epidemic of acral lesions highly suggestive of chilblains occurred during the COVID-19 pandemic,[@bb0045], [@bb0050], [@bb0055], [@bb0060] and this eruption can be considered as a paraviral manifestation of COVID-19. This condition was found mainly in children and young adults who did not have a history of chilblains. It occurred about 3 to 4 weeks either after contact with an infected person in asymptomatic individuals or after minor signs of COVID-19. Infection with COVID-19 could almost never be documented in those patients. None of the patients developed pneumonia. Lesions occurred mainly on the toes ([Figure 2](#f0010){ref-type="fig"} ) and the fingers. Lesions persisted about 10 to 20 days. They manifested as papules, plaques, or swellings, sometimes accompanied by pain and/or itch. When the lesions were biopsied, they displayed the findings of chilblains, but no signs suggestive of a cytopathogenic viral effect.[@bb0065] The majority of patients who developed chilblains were seronegative[@bb0065], [@bb0070], [@bb0075] (personal observation).Fig. 2Erythematous papules on toes, which appeared 19 days after clinical manifestations of possible coronavirus disease 2019 (fever, headache, myalgia) in a 26-year-old woman. Nasopharyngeal swab and serology were negative.Fig. 2

Why is it important to distinguish between viral and paraviral skin manifestations of COVID-19? {#s0020}
===============================================================================================

A viral eruption means active disease with viremia, and thus the patient is at risk to develop the other manifestations of COVID-19. Such patients need surveillance, because they can contribute to spreading the disease. They need to be quarantined.

In the case of COVID-19, paraviral chilblains mean that the patient had had contact with the virus and was able to reject it. Those patients are not at risk for pneumonia, and they do not contribute to spreading the disease.

What is the significance of paraviral chilblain lesions in patients with COVID-19? {#s0025}
==================================================================================

The facts include the following:1.Chilblains occurred exclusively in pauci- or asymptomatic patients about 1 to 4 weeks after minor findings of COVID-19 or contact with a patient.2.The majority of patients were not found to bear the virus by nasopharyngeal swabs.

Many of them did not develop specific anti-SARS-CoV-2 antibodies, which suggests that they might have a natural resistance to the virus, as I have hypothesized elsewhere.[@bb0080] These findings suggest that their innate immune system rejects the virus and that the adaptive immune system does not need to intervene, explaining the lack of specific antibodies.

Interestingly, children with rare monogenic disorders leading to an enhanced antiviral innate immune response also develop chilblains, supporting this hypothesis. These disorders are called type 1 interferonopathies and include such entities as the different Aicardi-Goutières syndromes or STING (STimulator of INterferon Genes)-associated vasculopathy with onset in infancy.[@bb0085] It is possible that the otherwise asymptomatic individuals who developed chilblains after COVID-19 do have variants of genes involved in this pathway that confer them a natural resistance to COVID-19.

I leave it up to other investigators to carefully analyze all the other numerous cutaneous manifestations that have been reported in patients with COVID-19 in the last few months. It will be up to them to determine the association with SARS-CoV-2 and the meaning of the findings in terms of viral versus paraviral.

Conclusions {#s0030}
===========

The mechanisms discussed in this short review on the meaning of skin findings during COVID-19 probably apply to the disease process in general. Some signs are the direct consequence of the virus interacting with an organ, whereas others are the consequence of activation of the immune system. This is important because therapy and care of the patients will not be the same whether the target is the virus or the immune system.
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[^1]: CMV, cytomegalovirus; EBV, Epstein-Barr virus; HHV, human herpes virus.
